Keisuke Komiya

1PUBLICATIONS
8CO-AUTHORS
Basic pharmacology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Feb 09, 2023
Determining the optimal initial dose for Japanese patients with nocturnal polyuria using an initial dose of desmopressin 50 μg.

Hirofumi Kurose, Keisuke Komiya, Naoyuki Ogasawara

Pageof 1

Frequent Collaborators

1 joint publications

Hirofumi Kurose

1 joint publications

Naoyuki Ogasawara

1 joint publications

Kosuke Ueda

1 joint publications

Katsuaki Chikui

1 joint publications

Kiyoaki Nishihara

1 joint publications

Makoto Nakiri

1 joint publications

Shigetaka Suekane

1 joint publications

Tsukasa Igawa

Frequent Collaborators

1 joint publications

Hirofumi Kurose

1 joint publications

Naoyuki Ogasawara

1 joint publications

Kosuke Ueda

1 joint publications

Katsuaki Chikui

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
08:44

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema

Published on : Sep 01, 2016

8.9K
See more related videos

Top Related Videos

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
08:44

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema

Published on : Sep 01, 2016

8.9K
See more related videos